Drug Trial Radar · NCT03573960
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Apr 1, 2018
Primary completion
Sep 4, 2025
Study completion Sep 4, 2025
Sponsor
- Lead sponsor
- Eisai Pharmaceuticals India Pvt. LtdEisai
- Sponsor type
- Industry
- First posted
- Jun 29, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of lenvatinib in participants with recurrent, metastatic radio-iodine refractory differentiated thyroid cancer (DTC).
Conditions
- Thyroid Neoplasms
Interventions
LenvatinibDrug
Lenvatinib capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with Grade 2 or Higher Treatment-emergent Adverse EventsTime frame: Baseline up to Week 24
- Number of Dose ReductionsTime frame: Baseline up to Week 24
- Median Time to First Dose ReductionTime frame: Baseline up to Week 24
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Tata Memorial Hospital
Mumbai, India
BL Kapoor Hospital, New Delhi
New Delhi, India
Indrayani Hospital, Alandi
Pune, India
City Cancer Centre
Vijayawada, India
Shetty's Hospital
Bangalore, Karnataka, India
Regional Cancer Centre, RCC, Thiruvananthapuram
Thiruvananthapuram, Kerala, India
Deenanath Mangeshkar Hospital
Pune, Maharashtra, India
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
Indraprastha Apollo Hospital
New Delhi, National Capital Territory of Delhi, India
All India Institute of Medical Sciences
Bhubaneswar, Odisha, India
S. P. Medical College & A. G. Hospitals
Bikaner, Rajasthan, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.